CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 125 enrolled
Drug / intervention
clobetasol propionate 0.05% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01323673
NCT01323673Phase 4Completed
CompareCT.gov

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

Stiefel, a GSK Company·interventional·Posted Mar 25, 2011·Updated Jun 20, 2018

In Brief

A Phase 4 clinical trial evaluating clobetasol propionate 0.05% and Vehicle / Placebo for Dermatitis, Chronic. Completed, enrolled 125 participants across 10 sites.

Detailed Summary

The purpose of this study is to determine how clobetasol proprionate foam works against a placebo foam in the treatment of hand dermatitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDermatitis, Chronic
CountriesUnited States
CollaboratorsGlaxoSmithKline

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 25, 2011
Enrollment StartNov 15, 2010
Primary CompletionMar 1, 2011
Study CompletionMar 29, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.3 years ago

Interventions

clobetasol propionate 0.05%drug

2 times a day, 14 total days study treatment

Vehicle / Placebodrug

2 times a day, 14 total days of study treatment